Review
Pharmacogenomic testing: Relevance in medical practice
Why drugs work in some patients but not in others
Joseph P. Kitzmiller, MD, PhD, David K. Groen, MD, Mitch A. Phelps, PhD and Wolfgang Sadee, Dr rer nat
Cleveland Clinic Journal of Medicine April 2011, 78 (4) 243-257; DOI: https://doi.org/10.3949/ccjm.78a.10145
Joseph P. Kitzmiller
Department of Pharmacology, Division of Clinical Trials, College of Medicine, The Ohio State University, Columbus, OH
David K. Groen
Department of Pharmacology, Division of Clinical Trials, College of Medicine, The Ohio State University, Columbus, OH
Mitch A. Phelps
Division of Pharmaceutics Resources, College of Pharmacy, The Ohio State University, Columbus, OH
Wolfgang Sadee
Chairman, Department of Pharmacology; Director, Program in Pharmacogenomics, College of Medicine, The Ohio State University, Columbus, OH
In this issue
Cleveland Clinic Journal of Medicine
Vol. 78, Issue 4
1 Apr 2011
Pharmacogenomic testing: Relevance in medical practice
Joseph P. Kitzmiller, David K. Groen, Mitch A. Phelps, Wolfgang Sadee
Cleveland Clinic Journal of Medicine Apr 2011, 78 (4) 243-257; DOI: 10.3949/ccjm.78a.10145
Jump to section
Related Articles
- No related articles found.
Cited By...
- Epigenetic Mechanisms Contribute to Intraindividual Variations of Drug Metabolism Mediated by Cytochrome P450 Enzymes
- Optimizing Choice of Dual Antiplatelet Therapy in CYP2C19 Loss-of-Function Carriers
- Personalised antiplatelet therapy based on pharmacogenomics in acute ischaemic minor stroke and transient ischaemic attack: study protocol for a randomised controlled trial
- Genetic Polymorphisms and Clopidogrel Efficacy for Acute Ischemic Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis